The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 13, 2022
Filed:
Jun. 29, 2017
Applicants:
Healios K.k., Tokyo, JP;
Sumitomo Pharma Co., Ltd., Osaka, JP;
Inventors:
Dai Otagiri, Kobe, JP;
Tadao Maeda, Kobe, JP;
Assignees:
HEALIOS K.K., Tokyo, JP;
SUMITOMO PHARMA CO., LTD., Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/30 (2015.01); A01N 1/02 (2006.01); A61K 9/10 (2006.01); A61K 47/02 (2006.01); A61K 47/34 (2017.01); A61L 27/38 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/42 (2017.01); A61L 27/36 (2006.01); A61L 27/50 (2006.01);
U.S. Cl.
CPC ...
A61K 35/30 (2013.01); A01N 1/0221 (2013.01); A61K 9/10 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 47/34 (2013.01); A61K 47/42 (2013.01); A61L 27/3687 (2013.01); A61L 27/3691 (2013.01); A61L 27/3804 (2013.01); A61L 27/505 (2013.01); A61L 2430/16 (2013.01);
Abstract
The present invention, in which RPE cells are suspended in a medium pharmaceutically acceptable as an ocular irrigating/washing solution and containing a poloxamer, achieves improvement of the post-thawing survival rate of cryopreserved RPE cells, improvement of the photoreceptor cell protection effect by RPE cell transplanted immediately after thawing, and prevention of loss of RPE cells in various steps from thawing to transplantation.